Healthcare -
Biotechnology - NASDAQ - US
$ 6.96
0 %
$ 476 M
Market Cap
-1.21
P/E
PHAT - CASH & EQUIVALENTS
Cash & Equivalents PHAT - Phathom Pharmaceuticals, Inc.
381 M
LAST VALUE
44.26%
2 YEAR CAGR
236.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR